LINGEGOWDA SELANERE MANGALA's research topics

LINGEGOWDA SELANERE MANGALA

Concepts (534)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with LINGEGOWDA SELANERE MANGALA's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that LINGEGOWDA SELANERE MANGALA has written about over time.

Transglutaminases, 5 publications between 2005 and 2008, average publication date June 2006. Aptamers, Nucleotide, 2 publications between 2010 and 2016, average publication date June 2013. RNA, Small Interfering, 27 publications between 2006 and 2021, average publication date July 2013. Receptor, EphA2, 9 publications between 2006 and 2024, average publication date October 2013. Apoptosis, 31 publications between 2005 and 2024, average publication date October 2013. Ovarian Neoplasms, 58 publications between 2006 and 2022, average publication date February 2014. Neovascularization, Pathologic, 20 publications between 2006 and 2021, average publication date April 2014. Antineoplastic Agents, 21 publications between 2006 and 2023, average publication date May 2014. Nanoparticles, 12 publications between 2010 and 2018, average publication date May 2014. Mice, Nude, 49 publications between 2006 and 2021, average publication date July 2014. Cell Line, Tumor, 67 publications between 2005 and 2024, average publication date September 2014. Xenograft Model Antitumor Assays, 31 publications between 2008 and 2021, average publication date January 2015. Animals, 90 publications between 2005 and 2024, average publication date January 2015. Mice, 75 publications between 2006 and 2024, average publication date February 2015. Drug Resistance, Neoplasm, 18 publications between 2005 and 2021, average publication date April 2015. Gene Expression Regulation, Neoplastic, 29 publications between 2005 and 2021, average publication date October 2015. Chitosan, 7 publications between 2010 and 2022, average publication date November 2015. Cisplatin, 7 publications between 2009 and 2019, average publication date November 2015. RNA Interference, 9 publications between 2009 and 2021, average publication date January 2016. MicroRNAs, 20 publications between 2011 and 2022, average publication date February 2017.

Transglutaminases
Aptamers, Nucleotide
RNA, Small Interfering
Receptor, EphA2
Apoptosis
Ovarian Neoplasms
Neovascularization, Pathologic
Antineoplastic Agents
Nanoparticles
Mice, Nude
Cell Line, Tumor
Xenograft Model Antitumor Assays
Animals
Mice
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Chitosan
Cisplatin
RNA Interference
MicroRNAs

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Transglutaminases	5	2005	2008	June 2006
Aptamers, Nucleotide	2	2010	2016	June 2013
RNA, Small Interfering	27	2006	2021	July 2013
Receptor, EphA2	9	2006	2024	October 2013
Apoptosis	31	2005	2024	October 2013
Ovarian Neoplasms	58	2006	2022	February 2014
Neovascularization, Pathologic	20	2006	2021	April 2014
Antineoplastic Agents	21	2006	2023	May 2014
Nanoparticles	12	2010	2018	May 2014
Mice, Nude	49	2006	2021	July 2014
Cell Line, Tumor	67	2005	2024	September 2014
Xenograft Model Antitumor Assays	31	2008	2021	January 2015
Animals	90	2005	2024	January 2015
Mice	75	2006	2024	February 2015
Drug Resistance, Neoplasm	18	2005	2021	April 2015
Gene Expression Regulation, Neoplastic	29	2005	2021	October 2015
Chitosan	7	2010	2022	November 2015
Cisplatin	7	2009	2019	November 2015
RNA Interference	9	2009	2021	January 2016
MicroRNAs	20	2011	2022	February 2017

MANGALA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (534)

Explore

Co-Authors (74)

Explore

Similar People (60)

Explore

Same Department

Explore